Pages that link to "Q33772210"

The following pages link to NK1, a Natural Splice Variant of Hepatocyte Growth Factor/Scatter Factor, Is a Partial Agonist In Vivo (Q33772210):

Displaying 25 items.

• Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor. (Q27635335) (← links)
• A new crystal form of the NK1 splice variant of HGF/SF demonstrates extensive hinge movement and suggests that the NK1 dimer originates by domain swapping (Q27639093) (← links)
• A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist (Q27647900) (← links)
• Immunohistochemical localization of hepatocyte growth factor activator (HGFA) in developing mouse liver tissues. Heterogeneous distribution of HGFA protein (Q28592355) (← links)
• Noncoding mutations of HGF are associated with nonsyndromic hearing loss, DFNB39. (Q30484106) (← links)
• Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis (Q33786959) (← links)
• The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B-cell differentiation. (Q33922881) (← links)
• In Vivo Expression of HGF/NK1 and GLP-1 From dsAAV Vectors Enhances Pancreatic β-Cell Proliferation and Improves Pathology in the db/db Mouse Model of Diabetes (Q34355256) (← links)
• Differential mitogenic effects of single chain hepatocyte growth factor (HGF)/scatter factor and HGF/NK1 following cleavage by factor Xa. (Q35677691) (← links)
• Prenatal expression of MET receptor tyrosine kinase in the fetal mouse dorsal raphe nuclei and the visceral motor/sensory brainstem (Q37101439) (← links)
• Targeting MET in cancer: rationale and progress (Q37978193) (← links)
• Intracellular signaling cascades triggered by the NK1 fragment of hepatocyte growth factor in human prostate epithelial cell line PNT1A (Q39503087) (← links)
• SF/HGF-c-Met autocrine and paracrine promote metastasis of hepatocellular carcinoma. (Q40749632) (← links)
• Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis (Q40755904) (← links)
• Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-met interaction facilitates signaling (Q40795221) (← links)
• An engineered dimeric fragment of hepatocyte growth factor is a potent c-MET agonist (Q42088207) (← links)
• CCl4-induced acute liver injury in mice is inhibited by hepatocyte growth factor overexpression but stimulated by NK2 overexpression (Q44249525) (← links)
• The N-terminal domain of hepatocyte growth factor inhibits the angiogenic behavior of endothelial cells independently from binding to the c-met receptor (Q44504094) (← links)
• dsAAV8-mediated gene transfer and β-cell expression of IL-4 and β-cell growth factors are capable of reversing early-onset diabetes in NOD mice (Q45875053) (← links)
• CAR T-cell immunotherapy of MET-expressing malignant mesothelioma (Q47280088) (← links)
• Insights into the structure of hepatocyte growth factor/scatter factor (HGF/SF) and implications for receptor activation. (Q47789114) (← links)
• Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling (Q50977853) (← links)
• Exploring the chemical space of the lysine-binding pocket of the first kringle domain of hepatocyte growth factor/scatter factor (HGF/SF) yields a new class of inhibitors of HGF/SF-MET binding (Q57360231) (← links)
• Plasma hepatocyte growth factor as a marker for small-for-gestational age fetuses (Q63359247) (← links)
• A Human Recombinant IL-7/HGFα Hybrid Cytokine Enhances T-Cell Reconstitution in Mice After Syngeneic Bone Marrow Transplantation (Q84580150) (← links)